ARVN
Price
$7.84
Change
-$0.05 (-0.63%)
Updated
Jul 25 closing price
Capitalization
572.25M
3 days until earnings call
CYCCP
Price
$4.70
Change
-$0.14 (-2.89%)
Updated
Jul 25, 11:15 AM (EDT)
Capitalization
31.65
Interact to see
Advertisement

ARVN vs CYCCP

Header iconARVN vs CYCCP Comparison
Open Charts ARVN vs CYCCPBanner chart's image
Arvinas
Price$7.84
Change-$0.05 (-0.63%)
Volume$1.59M
Capitalization572.25M
Cyclacel Pharmaceuticals
Price$4.70
Change-$0.14 (-2.89%)
VolumeN/A
Capitalization31.65
ARVN vs CYCCP Comparison Chart in %
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYCCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. CYCCP commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a StrongBuy and CYCCP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (ARVN: $7.84 vs. CYCCP: $4.84)
Brand notoriety: ARVN and CYCCP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 81% vs. CYCCP: 135%
Market capitalization -- ARVN: $572.25M vs. CYCCP: $31.65
ARVN [@Biotechnology] is valued at $572.25M. CYCCP’s [@Biotechnology] market capitalization is $31.65. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 1 FA rating(s) are green whileCYCCP’s FA Score has 1 green FA rating(s).

  • ARVN’s FA Score: 1 green, 4 red.
  • CYCCP’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARVN and CYCCP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 5 TA indicator(s) are bullish while CYCCP’s TA Score has 5 bullish TA indicator(s).

  • ARVN’s TA Score: 5 bullish, 3 bearish.
  • CYCCP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ARVN and CYCCP are a good buy in the short-term.

Price Growth

ARVN (@Biotechnology) experienced а +6.67% price change this week, while CYCCP (@Biotechnology) price change was -8.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ARVN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARVN($572M) has a higher market cap than CYCCP($31.65). CYCCP YTD gains are higher at: -29.380 vs. ARVN (-59.103). ARVN has more cash in the bank: 954M vs. CYCCP (93K). CYCCP has less debt than ARVN: CYCCP (9K) vs ARVN (10.5M).
ARVNCYCCPARVN / CYCCP
Capitalization572M31.651,807,042,019%
EBITDA-89.3MN/A-
Gain YTD-59.103-29.380201%
P/E RatioN/AN/A-
Revenue427MN/A-
Total Cash954M93K1,025,806%
Total Debt10.5M9K116,667%
FUNDAMENTALS RATINGS
ARVN vs CYCCP: Fundamental Ratings
ARVN
CYCCP
OUTLOOK RATING
1..100
2950
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
1
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
86100
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYCCP's Valuation (1) in the Biotechnology industry is in the same range as ARVN (16). This means that CYCCP’s stock grew similarly to ARVN’s over the last 12 months.

CYCCP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARVN (100). This means that CYCCP’s stock grew similarly to ARVN’s over the last 12 months.

ARVN's SMR Rating (86) in the Biotechnology industry is in the same range as CYCCP (100). This means that ARVN’s stock grew similarly to CYCCP’s over the last 12 months.

ARVN's Price Growth Rating (65) in the Biotechnology industry is in the same range as CYCCP (65). This means that ARVN’s stock grew similarly to CYCCP’s over the last 12 months.

ARVN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CYCCP (100). This means that ARVN’s stock grew similarly to CYCCP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARVNCYCCP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
81%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYCCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSMYX23.940.28
+1.18%
Goldman Sachs Small/Mid Cap Growth Instl
IDHCX19.370.03
+0.16%
Integrity Dividend Harvest C
ENHRX10.60-0.01
-0.09%
Cullen Enhanced Equity Income Retail
RALYX10.75-0.03
-0.28%
Lazard Real Assets R6
ARTIX35.09-0.12
-0.34%
Artisan International Investor

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with ERAS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-0.63%
ERAS - ARVN
39%
Loosely correlated
+1.75%
GMAB - ARVN
39%
Loosely correlated
-0.97%
CRGX - ARVN
36%
Loosely correlated
N/A
TECH - ARVN
35%
Loosely correlated
+0.53%
TRML - ARVN
35%
Loosely correlated
+5.44%
More

CYCCP and

Correlation & Price change

A.I.dvisor tells us that CYCCP and ARVN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCCP and ARVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCCP
1D Price
Change %
CYCCP100%
N/A
ARVN - CYCCP
29%
Poorly correlated
-0.63%
VALN - CYCCP
23%
Poorly correlated
+4.99%
MLEC - CYCCP
23%
Poorly correlated
-4.45%
PROK - CYCCP
22%
Poorly correlated
+0.92%
ADIL - CYCCP
21%
Poorly correlated
+7.04%
More